by admin | Oct 27, 2025 | News & Opinions
By Drug Target Review – UCLA researchers have developed a monoclonal antibody, AD-NP1, that blocks ENPP1 to enhance heart repair and reduce scar tissue. Injuries like cuts to the skin tend to heal naturally, but damage to internal organs like the heart or...
by admin | Oct 24, 2025 | News & Opinions
by Bioenginee.org – In a groundbreaking study published in Scientific Reports, researchers have unveiled significant findings surrounding the long-term effects of growth hormone therapy in pediatric patients suffering from growth hormone deficiency. This...
by admin | Oct 23, 2025 | News & Opinions
By Jess Cockerill – Science Alert – Clusters of cells grown in the lab have been encouraged to produce human blood stem cells in a discovery that could one day supplement donations to people with blood disorders like leukemia and lymphoma. The University...
by admin | Oct 22, 2025 | News & Opinions
By Molecular Systems Biology – Abstract Precision medicine for paediatric and adult cancers that incorporates drug sensitivity profiling can identify effective therapies for individual patients. However, obtaining adequate biopsy samples for high-throughput...
by admin | Oct 21, 2025 | News & Opinions
By Drug Target Review – USC researchers have engineered CAR T cells to deliver a dual protein therapy that targets solid tumours – offering hope for cancers previously resistant to treatment. Chimeric antigen receptor (CAR) T-cell therapy, which uses a patient’s...
by admin | Oct 20, 2025 | News & Opinions
by Tristan Manalac – BioSpace – Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move. Takeda will no longer invest in cell therapies moving...
